JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lahoutte, T.
Right arrow Articles by Everaert, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lahoutte, T.
Right arrow Articles by Everaert, H.
Journal of Nuclear Medicine Vol. 43 No. 9 1201-1206
© 2002 by Society of Nuclear Medicine


Basic Science Investigations

Increased Tumor Uptake of 3-123I-Iodo-L-{alpha}-Methyltyrosine After Preloading with Amino Acids: An In Vivo Animal Imaging Study

Tony Lahoutte, MD1, Vicky Caveliers, Pharm1, Philippe R. Franken, MD, PhD1, Axel Bossuyt, MD, PhD1, John Mertens, PhD1 and Hendrik Everaert, MD, PhD1

1 Division of Nuclear Medicine, Academic Hospital, Free University Brussels, Brussels, Belgium

3-123I-Iodo-L-{alpha}-methyltyrosine (3-IMT) is an amino acid analog used for tumor imaging. Specific accumulation is mediated mainly by the system L amino acid transport system. System L activity is known to increase when cells are loaded with amino acids. The aim of our study was to measure the effects of amino acid preload on 123I-3-IMT tumor uptake and image contrast in a rat tumor model using in vivo dynamic imaging. Methods: Rhabdomyosarcoma (R1M) tumor-bearing rats underwent 2 dynamic 123I-3-IMT studies on separate days: 1 baseline study and 1 after intraperitoneal injection (0.25 mmol/kg) of a single amino acid (arginine, proline, glutamate, asparagine, tryptophan, or phenylalanine) administered 30 min before intravenous injection of 18.5 MBq 123I-3-IMT. A 99mTc-labeled human serum albumin study was performed on each rat for the calculation of the blood-pool activity inside the tumor. Time-activity curves were generated for tumor, contralateral background region, kidney, heart, and total body. Tumor uptake was corrected for blood-pool and background activity. Image contrast was calculated as the ratio between tumor and background activity. The rate (K1) of tracer entering the tumor was obtained using Patlak analysis. A displacement study was performed on a separate group of rats, in which a high dose of phenylalanine was administered 40 min after 123I-3-IMT injection. Results: 123I-3-IMT accumulation in tumor reached a plateau 10 min after injection. Tumor uptake on the baseline scans correlated well with tumor size (r = 0.92). After preloading, tumor uptake and contrast increased in all conditions: arginine, +26% and +26%; proline, +15% and +13%; glutamate, +14% and +9%; asparagine, +19% and +15%; tryptophan, +36% and 11%; phenylalanine, +22% and + 13%. K1 values also increased. Administration of an afterload with phenylalanine induced a significant displacement of 123I-3-IMT tumor accumulation. Conclusion: Prior amino acid administration increases 123I-3-IMT tumor accumulation and image contrast. This effect can be explained by the increased antiporter activity of the amino acid transport system L in preloaded conditions. Our results indicate that the fasted state might not be the optimal metabolic condition to study tumor accumulation of L-transported tracers such as 123I-3-IMT. Amino acid administration before 123I-3-IMT injection could improve tumor uptake and image contrast.

Key Words: 3-123I-iodo-L-{alpha}-methyltyrosine • tumor imaging • system L • amino acid preload




This article has been cited by other articles:


Home page
JNMHome page
R. Bergmann, J. Pietzsch, F. Fuechtner, B. Pawelke, B. Beuthien-Baumann, B. Johannsen, and J. Kotzerke
3-O-Methyl-6-18F-Fluoro-L-Dopa, a New Tumor Imaging Agent: Investigation of Transport Mechanism In Vitro
J. Nucl. Med., December 1, 2004; 45(12): 2116 - 2122.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
T. Lahoutte, V. Caveliers, S. M.R. Camargo, R. Franca, T. Ramadan, E. Veljkovic, J. Mertens, A. Bossuyt, and F. Verrey
SPECT and PET Amino Acid Tracer Influx via System L (h4F2hc-hLAT1) and Its Transstimulation
J. Nucl. Med., September 1, 2004; 45(9): 1591 - 1596.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
P. L. Jager
Improving Amino Acid Imaging: Hungry or Stuffed?
J. Nucl. Med., September 1, 2002; 43(9): 1207 - 1209.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.